Belite Bio, Inc. ADR's market cap is currently ―. The company's EPS TTM is $-1.241; its P/E ratio is -26.92; Belite Bio, Inc. ADR is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Jun 22	Dec 21
Income Statement	-
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
EBIT	-	-	-	-
EBITDA	-	-	-	-
Net Income Common Stockholders	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 88.16M	$ 42.09M	$ 0.00	$ 17.34M
Total Assets	$ 94.64M	$ 44.27M	$ 51.06M	$ 18.35M
Total Debt	$ 886.00K	$ 866.00K	$ 0.00	$ 0.00
Net Debt	$ -87.27M	$ -41.22M	$ 0.00	$ -17.34M
Total Liabilities	$ 4.21M	$ 2.77M	$ 1.43M	$ 33.44M
Stockholders Equity	$ 90.43M	$ 41.50M	$ 49.63M	$ -15.09M
Cash Flow	-
Free Cash Flow	-	-	-	-
Operating Cash Flow	-	-	-	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-	-	-	-

Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History

Income Statement >

Belite Bio, Inc. ADR Debt to Assets

Balance Sheet >

Belite Bio, Inc. ADR Cash Flow

Cash Flow >

Belite Bio, Inc. ADR Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing